Author

A. S. Kucey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

B. L. Urquhart· 2 shared A. Engineer· 1 shared E. D. Hartjes· 1 shared G. B. Gloor· 1 shared G. Reid· 1 shared J. M. Macklaim· 1 shared J. P. Burton· 1 shared K. F. Al· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

B. L. Urquhart

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The Impact of Uremia and Intestinal Dysbiosis on Hepatic Drug Metabolism in a Rat Model of Progressive Chronic Kidney Disease

E. D. Hartjes, Y. J. Lim, T. J. Velenosi, K. F. Al, J. M. Macklaim, A. S. Kucey, G. Reid, J. P. Burton, G. B. Gloor, B. L. Urquhart

This study investigates how uremia and intestinal dysbiosis affect hepatic drug metabolism in a rat CKD model, finding that CYP3A2 and CYP2C11 are downregulated before dysbiosis and correlate with uremic toxins.

bioRxiv · Jan 29, 2019 · PreprintPharmacology & Toxicology

Sapropterin Treatment Prevents Congenital Heart Defects Induced by Pregestational Diabetes in Mice

A. Engineer, T. Saiyin, X. Lu, A. S. Kucey, B. L. Urquhart, T. A. Drysdale, K. Norozi, Q. Feng

This study shows sapropterin reduces congenital heart defects in mouse offspring of diabetic mothers by improving eNOS coupling and cell proliferation.

bioRxiv · Jul 23, 2018Pharmacology & Toxicology